Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

AZD3293

- PMLiVE

Douglas Williams named president and CEO of Codiak

He joins from Biogen wherehe was executive VP of research and development

- PMLiVE

AZ sets price of new lung cancer drug Tagrisso

Price tag of $150,000 per year given

- PMLiVE

AZ’s Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge

- PMLiVE

GSK and AZ drugs impress in lupus trials

Raises hope for better treatment for debilitating disease

- PMLiVE

AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy

Acquires rights to potential best-in-class treatment for hyperkalaemia

- PMLiVE

Getting patients to engage with clinical trials

The EUPATI European initiative and increasing public knowledge of research

- PMLiVE

AstraZeneca backs heart website

Works with charity HEART UK on How Young My Heart

- PMLiVE

AZ moves a step closer to gout drug approval in US

Final verdict to be delivered in end of December

Executive vice president of Biogen leaves

Tony Kingsley departs the firm

Eli Lilly HQ

Lilly and AZ forge closer immuno-oncology bond

Look to boost their presence in a market predicted to be worth $30bn in 10 years

Biogen Idec building

Biogen cuts workforce and culls pipeline projects

Attempts to make major cost savings as MS drug sales slow

- PMLiVE

FDA rejects AZ’s diabetes combination

Wants to see more trial data on saxagliptin / dapagliflozin

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links